Mutational Analysis of the SLC4A11 Gene in a (Filipino) Family with Congenital Hereditary Endothelial Dystrophy
Abstract
:1. Introduction
2. Methodology
2.1. Clinical Studies
2.2. SLC4A11 Gene Mutation Screening Analysis
2.2.1. Sample Collection
2.2.2. DNA Extraction
2.2.3. Gene Amplification
2.2.4. DNA Sequencing and Mutational Analysis
3. Results
3.1. Clinical Examination and Demographics
3.2. Mutation Analysis
4. Discussion
4.1. Potential Functional Significance of Each Mutation
- Before Exon 1, (Novel Mutation) 4291G>A: The mutation located before Exon 1 is a novel finding. Further investigations, including reporter assays to assess potential effects on gene expression, are recommended.
- Between Exon 1 and 2, 6533G>C: This mutation has been associated with the CHED phenotype [15]. Subsequent experiments, particularly reporter assays, can elucidate its impact on gene expression.
- Exon 6, 10294G>C and 10307G>A: Two mutations were identified in Exon 6. The literature suggests that mutations in this region may also contribute to the CHED phenotype [15]. However, the Polyphen2 predictions were benign. Functional assays, especially electrophysiological studies, are warranted for validation.
- Between Exon 9 and 10, 13165T>C: This mutation, located between Exon 9 and 10, has been associated with the CHED phenotype [15]. Functional assays, including reporter assays, can provide further insights into its impact. Notably, it was absent in all patients, but present in Patient I-1.
4.2. Limitations of Polyphen Tool and Recommendations
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Nischal, K.K. Genetics of Congenital Corneal Opacification—Impact on Diagnosis and Treatment. Cornea 2015, 34, S24–S34. [Google Scholar] [CrossRef] [PubMed]
- Yanoff, M.; Duker, J.S. Ophthalmology: Expert Consult: Online and Print; Elsevier Health Sciences: Amsterdam, The Netherlands, 2013. [Google Scholar]
- Siddiqui, S.; Zenteno, J.C.; Rice, A.; Chacón-Camacho, O.; Naylor, S.G.; Rivera-de la Parra, D.; Spokes, D.M.; James, N.; Toomes, C.; Inglehearn, C.F.; et al. Congenital Hereditary Endothelial Dystrophy Caused by SLC4A11 Mutations Progresses to Harboyan Syndrome. Cornea 2014, 33, 247–251. Available online: https://journals.lww.com/corneajrnl/fulltext/2014/03000/congenital_hereditary_endothelial_dystrophy_caused.7.aspx (accessed on 22 May 2020). [CrossRef] [PubMed]
- Park, M.; Li, Q.; Shcheynikov, N.; Zeng, W.; Muallem, S. NaBC1 is a ubiquitous electrogenic Na+-coupled borate transporter essential for cellular boron homeostasis and cell growth and proliferation. Mol. Cell 2004, 16, 331–341. [Google Scholar] [CrossRef] [PubMed]
- Callaghan, M.; Hand, C.K.; Kennedy, S.M.; FitzSimon, J.S.; Collum, L.M.; Parfrey, N.A. Homozygosity mapping and linkage analysis demonstrates that autosomal recessive congenital hereditary endothelial dystrophy (CHED) and autosomal dominant CHED are genetically distinct. Br. J. Ophthalmol. 1999, 83, 115–119. [Google Scholar] [CrossRef] [PubMed]
- Hemadevi, B.; Veitia, R.A.; Srinivasan, M.; Arunkumar, J.; Prajna, N.V.; Lesaffre, C.; Sundaresan, P. Identification of Mutations in the SLC4A11 Gene in Patients with Recessive Congenital Hereditary Endothelial Dystrophy. Ophthalmic Mol. Genet. 2008, 126, 700–708. [Google Scholar] [CrossRef]
- Kim, J.H.; Ko, J.M.; Tchah, H. Fuchs Endothelial Corneal Dystrophy in a Heterozygous Carrier of Congenital Hereditary Endothelial Dystrophy Type 2 with a Novel Mutation in SLC4A11. Ophthalmic Genet. 2014, 36, 284–286. [Google Scholar] [CrossRef]
- Wang, X.; Zhu, Y.; Shen, N.; Peng, J.; Wang, C.; Liu, H.; Lu, Y. Mutation analysis of a Chinese family with oculocutaneous albinism. Oncotarget 2016, 7, 84981–84988. [Google Scholar] [CrossRef]
- Paliwal, P.; Sharma, A.; Tandon, R.; Sharma, N.; Titiyal, J.S.; Sen, S.; Nag, T.C.; Vajpayee, R.B. Congenital hereditary endothelial dystrophy—Mutation analysis of SLC4A11 and genotype-phenotype correlation in a North Indian patient cohort. Mol. Vis. 2010, 16, 2955–2963. [Google Scholar]
- Mahdieh, N.; Rabbani, B. An Overview of Mutation Detection Methods in Genetic Disorders. Iran. J. Pediatr. 2013, 23, 375–388. [Google Scholar] [PubMed]
- Vithana, E.N.; Morgan, P.E.; Ramprasad, V.; Tan, D.T.; Yong, V.H.; Venkataraman, D.; Venkatraman, A.; Yam, G.H.; Nagasamy, S.; Law, R.W.; et al. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum. Mol. Genet. 2008, 17, 656–666. [Google Scholar] [CrossRef] [PubMed]
- Kodaganur, S.G.; Kapoor, S.; Veerxappa, A.M.; Tontanahal, S.J.; Sarda, A.; Yathish, S.; Prakash, D.R.; Kumar, A. Mutation analysis of the SLC4A11 gene in Indian families with congenital hereditary endothelial dystrophy 2 and a review of the literature. Mol. Vis. 2013, 19, 1694–1706. [Google Scholar] [PubMed]
- Kumar, A.; Bhattacharjee, S.; Prakash, D.R.; Sadanand, C.S. Genetic analysis of two Indian families affected with congenital hereditary endothelial dystrophy: Two novel mutations in SLC4A11. Mol. Vis. 2007, 13, 39–46. [Google Scholar] [PubMed]
- Ehlers, N.; Módis, L.; Møller-Pedersen, T. A morphological and functional study of congenital hereditary endothelial dystrophy. Acta Ophthalmol. Scand. 1998, 76, 314–318. [Google Scholar] [CrossRef] [PubMed]
- Aldave, A.J.; Han, J.; Frausto, R.F. Genetics of the corneal endothelial dystrophies: An evidence-based review. Clin. Genet. 2013, 84, 109–119. [Google Scholar] [CrossRef] [PubMed]
- Adzhubei, I.A.; Schmidt, S.; Peshkin, L.; Ramensky, V.E.; Gerasimova, A.; Bork, P.; Kondrashov, A.S.; Sunyaev, S.R. A method and server for predicting damaging missense mutations. Nat. Methods 2010, 7, 248–249. [Google Scholar] [CrossRef] [PubMed]
- Chun, S.; Fay, J.C. Identification of deleterious mutations within three human genomes. Genome Res. 2009, 19, 1553–1561. [Google Scholar] [CrossRef] [PubMed]
- Reva, B.; Antipin, Y.; Sander, C. Predicting the functional impact of protein mutations: Application to cancer genomics. Nucleic Acids Res. 2011, 39, e118. [Google Scholar] [CrossRef] [PubMed]
SLC4A11 GENE | Forward primer (Location of the forward primer on SLC4A11 Gene) | Reverse Primer (Location of the reverse complement of the reverse primer on SLC4A11 Gene) | Expected Product Size | Annealing Temperature | |
Actual Exon Number Based on RefSeqGene on Chromosome 20 (NG_017072.1) | Designated Exon Number by Paliwal et al. [9], 2010 according to mRNA and cDNA Sequences (NM_032034) | ||||
Exon 2 | Exon 1 | 5′ CCTAGCAGATGGGCTAAGCA 3′ (6424–6443) | 5′ GAGCAAAGCCACAGGACTCT 3′ | 327 | 60 |
Exon 3–4 | Exon 2 and 3 | 5′ CGAGAGTGGGACAGTCCAG 3′ (9243–9261) | 5′ CTCCCTGTTGAGTGCTCCT 3′ | 515 | 61 |
Exon 5–6 | Exon 4 and 5 | 5′ TCCAGGAGCAGCTCAACAG 3′ (9774–9792) | 5′ CAGCCCTCTTCTCCCAAGTT 3′ | 647 | 55 |
Exon 7 | Exon 6 | 5’ CCAACCAACTTGGGAGAAGA 3′ (10434–10453) | 5′ CCTTCAGAGGCCAGGACAT 3′ | 390 | 52 |
Exon 8–9 | Exon 7 and 8 | 5′ AAAACCTGCTGCCAGTTCAT 3′ (12596–12615) | 5′ CCTAGGAATGGGGGATGG 3′ | 551 | 57 |
Exon 10–11 | Exon 9 and 10 | 5′ ACTGATGGTACGTGGCCTCT 3′ (13087–13106) | 5′ CGTCCATGCGTAGAAGGAGT 3′ | 527 | 58 |
Exon 11 | Exon 11 and 12 | 5′ TCTACATCCAGGGTGCAGTG 3′ (13499–13518) | 5′ CGTCCATGCGTAGAAGGAGT 3′ | 115 | 58 |
Exon 14–15 | Exon 13 and 14 | 5′ GAGCCCTTTCTCCCTGAGAT 3′ (14377–14396) | 5′ GGTTGTAGCGGAACTTGCTC 3′ | 583 | 61 |
Exon 16–17 | Exon 15 and 16 | 5′ CGGGAAATCGAGAGTGAGTT 3′ (14884–14903) | 5′ CGTCTCCTTCACGTTCACAA 3′ | 633 | 54 |
Exon 18–19 | Exon 17 and 18 | 5′ CTGGCCACATGGGACATAG 3′ (15454–15472) | 5′ CTAGGCAGGACCCCTCCTC 3′ | 556 | 61 |
Exon 20 | Exon 19 | 5′ CAGGAGGGGCTCCAGTCTA 3′ (16221–16239) | 5′ CTGTCCCTTGCATTCCACTT 3′ | 692 | 61 |
Putative Promoter Region 1 | 5′ GCCTTACTCACCCAATCTATGC 3′ (3921–3942) | 5′ CCCTGTCTCCTCCTTTCGAC 3′ | 679 | 61 | |
Putative Promoter Region 2 | 5′ GGAGGAGGAGAAGGACTTGC 3′ (4534–4553) | 5′ GCACACTCGCGCACTCAC 3′ | 532 | 61 |
Exon Number | Location | Exon Number | Location |
---|---|---|---|
Exon 1 | 5052–5147 | Exon 11 | 13397–13510 |
Exon 2 | 6654–6698 | Exon 12 | 13595–13727 |
Exon 3 | 9348–9500 | Exon 13 | 13982–14055 |
Exon 4 | 9625–9674 | Exon 14 | 14466–14718 |
Exon 5 | 9928–10159 | Exon 15 | 14790–14896 |
Exon 6 | 10240–10321 | Exon 16 | 14979–15147 |
Exon 7 | 10605–10728 | Exon 17 | 15231–15404 |
Exon 8 | 12694–12912 | Exon 18 | 15535–15730 |
Exon 9 | 13000–13093 | Exon 19 | 15814–15983 |
Exon 10 | 13184–13309 | Exon 20 | 16386–16820 |
Family 1 Generation No. | Age/Sex | CCT OD/OS | Age at PK | BCVA/OD | BCVA/OS | Complications | Position of Nucleotide Change in SLC4A11 Gene | |||
4291G>A (Before Exon 1) | 6533G>C (Between Exon 1 and 2) | 10294G>C 10307G>A (in Exon 6) | 13165T>C (Between Exon 9 and 10) | |||||||
I-1 | 57/M | - | - | 20/30 | 20/30 | - | Present | Present | Absent | Present |
I-2 | 57/F | - | - | 20/30 | 20/30 | - | Present | Present | Present | Absent |
II-1 * | 37/M | - | - | 20/640 | 20/800 | - | Present | Present | Present | Absent |
II-2 * | 35/M | - | - | 20/640 | 20/640 | - | Present | Present | Present | Absent |
II-4 * | 31/F | - | - | 20/800 | 20/800 | - | Present | Present | Present | Absent |
II-6 * | 27/F | >0.7 mm OU | 25 yrs. | 20/800 | 20/70 | Failed graft OD | Present | Present | Present | Absent |
II-7 * | 19/M | >0.7 mm OU | 17 yrs. | 20/30 | HM | Failed graft OS | Present | Present | Present | Absent |
II-8 | 16/M | - | - | 20/20 | 20/20 | - | Present | Present | Present | Either (Probably heterozygous) |
II-9 * | 11/F | - | - | 20/800 | 20/800 | - | Present | Present | Present | Absent |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cabahug, V.L.O.; Llido, J.P.S.; Cabral, L.K.D.; Maynes, T.L.; Pinuela, C.L.; Tayengco-Tiu, T.L.; Lim Bon Siong, R.; Enriquez, M.L.D. Mutational Analysis of the SLC4A11 Gene in a (Filipino) Family with Congenital Hereditary Endothelial Dystrophy. J. Clin. Transl. Ophthalmol. 2024, 2, 34-46. https://doi.org/10.3390/jcto2020004
Cabahug VLO, Llido JPS, Cabral LKD, Maynes TL, Pinuela CL, Tayengco-Tiu TL, Lim Bon Siong R, Enriquez MLD. Mutational Analysis of the SLC4A11 Gene in a (Filipino) Family with Congenital Hereditary Endothelial Dystrophy. Journal of Clinical & Translational Ophthalmology. 2024; 2(2):34-46. https://doi.org/10.3390/jcto2020004
Chicago/Turabian StyleCabahug, Vicente Lorenzo O., John Paul S. Llido, Loraine Kay D. Cabral, Tricia L. Maynes, Cathlyn Leigh Pinuela, Tommee Lynne Tayengco-Tiu, Ruben Lim Bon Siong, and Ma. Luisa D. Enriquez. 2024. "Mutational Analysis of the SLC4A11 Gene in a (Filipino) Family with Congenital Hereditary Endothelial Dystrophy" Journal of Clinical & Translational Ophthalmology 2, no. 2: 34-46. https://doi.org/10.3390/jcto2020004